Yingmiao Liu

2.9k citations
62 papers · 2.2k indexed · h-index 24
Topics
Angiogenesis and VEGF in Cancer (8 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers)Colorectal Cancer Treatments and Studies (6 papers)

In The Last Decade

Yingmiao Liu

61 papers receiving 2.2k citations

Peers

Yingmiao Liu
Comparison fields: 5 of 112
  • Molecular Biology 1.4k
  • Oncology 440
  • Immunology 396
  • Biomedical Engineering 218
  • Genetics 212
Replace Alicia R. Folgueras with:
Alicia R. Folgueras Spain
Yongyan Wu China
Xuhua Zhang China
Mei Zhao China
Dorothea Maetzel United States
D. Stave Kohtz United States
Shuangli Mi China
Tobias Cantz Germany
Sylvain L. Guérin Canada
Yingmiao Liu relative to Alicia R. Folgueras Spain Alicia R. Folgueras's profile →
Citations per field
00.5×5.5×
Alicia R. Folgueras · 1×
Citations per year

Countries citing papers authored by Yingmiao Liu

Since Specialization
Citations

This map shows the geographic impact of Yingmiao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingmiao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingmiao Liu more than expected).

Fields of papers citing papers by Yingmiao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingmiao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingmiao Liu. The network helps show where Yingmiao Liu may publish in the future.

Co-authorship network of co-authors of Yingmiao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingmiao Liu. A scholar is included among the top collaborators of Yingmiao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingmiao Liu. Yingmiao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 3
4 9
5 2
6 150
7 37
8 15
9 34
10 33
11 103
12 60
13 15
14 18
15 59
16 27
17
Tumor targeting aptamers identified by in vivo SELEX
1
18 6
19 18
20 50

About Yingmiao Liu

Yingmiao Liu is a scholar working on Aging, Cancer Research and Oncology, having authored 62 papers that have together received 2.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Aging (35 citations) and Immunology (396 citations). Yingmiao Liu has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Bruce A. Sullenger, Andrew B. Nixon, Jing Mi, Bryan M. Clary, Sheng Yang, Zahid N. Rabbani, Yu Jiang, Fenghui Qian, Bingbing Sun and Zhongguang Yang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026